News | June 28, 2012

LifeWatch V Smartphone With Healthcare Capabilities Expands Possibility of Remote Patient Monitoring

June 28, 2012 — LifeWatch AG, a wireless cardiac monitoring service and home sleep test provider in the United States, presents LifeWatch V, the world’s first-of-its-kind healthcare smartphone. The fully featured state-of-the-art smartphone allows patients as well as health- and wellbeing-conscious consumers to self-operate a wide range of highly valuable embedded medical sensors, wellness-related applications, cloud-based services and 24/7 call center support.

The solution offers multiple sophisticated embedded medical miniature sensors, wellness-related applications, cloud-based services and 24/7 call center support. By using the barely visible sensors on the phone’s frame, patients as well as health- and wellbeing conscious consumers can track, capture, collect and analyze their health and medical measurements anywhere anytime. The features include ECG, body temperature, blood glucose, heart rate, blood oxygen saturation, body fat percentage and stress levels (heart rate variability). All collected data can be retrieved from the cloud for a follow-up anytime anywhere. Users can thus take corrective action, plan their diets and activities, securely share the information with a health provider or family member, trend and analyze the data and more. Patients are also able to program the unit to remind them of their drug type, dose and intake time.

Based on a full and complete Go-to-Market analysis LifeWatch intends to launch the healthcare solution smartphone world-wide. In the initial markets LifeWatch has identified several local partners to enter into strategic partnerships.

For more information: www.lifewatch.com 


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now